Profound Medical Corp's stock takes a hit, dropping over 3% in a single trading day.
Profound Medical Corp (PRN.TO) saw its stock price decline by 3.05%, closing at CA$9.54 in the latest trading session. This drop comes despite the company announcing strong revenue growth and strategic collaborations, which raises some concerns among investors.
Advertisement
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeAdvertisement
Market cap
$353.93M
52W high
$12.40
52W low
$5.23
1W change
-13.29%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 157.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+157.5% Upside
Current Price
C$9.72
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
59.9%
Annualized
90-Day Vol
54.1%
Annualized
Trend (90d)
+9.2%
Annualized drift
90d Mean
C$10.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.83 | C$7.99 – C$12.08 |
| 60 trading days | C$9.93 | C$7.42 – C$13.31 |
| 90 trading days | C$10.04 | C$7.02 – C$14.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as Profound Medical's recent performance might reflect underlying market uncertainties, even with positive growth narratives.
Stock Down 3.05% in One Day
With a market cap of CA$357.56 million, the decline in stock price shows investor apprehension, despite the company’s strong revenue growth.
Bull case
Profound Medical has reported impressive revenue growth, with a 104% increase in Q1 2026. If this trend continues, it could indicate strong future performance for the company.
Bear case
The recent stock slide raises questions about market confidence in Profound Medical, especially given its ongoing financial challenges and lack of profitability.
Stock Performance Overview
Advertisement
In the latest trading session, Profound Medical Corp's stock fell by 3.05%, closing at CA$9.54. This decline is particularly notable considering the company's recent announcements of strong revenue growth, suggesting a disconnect between market perception and actual performance.
Market Sentiment and Future Outlook
Despite reporting a 104% revenue growth in Q1 2026, investor sentiment appears cautious. The company's lack of profitability and the recent stock decline indicate that investors are weighing the risks against potential future growth. For more insights on Profound Medical, check out our detailed analysis on PRN.TO.
Key Financial Metrics
Profound Medical's current market cap is CA$357.56 million, and with a negative profit margin of -2.0676%, the company faces challenges in achieving sustainable profitability. Investors should consider these metrics when evaluating the stock's potential. For further details, visit our page on PRN.TO.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
